Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2370879 | 0.87 | CYP1A2 (0.41) | CYP1A2ALDH1A1CYP2C19 | |
| SCHEMBL2860348 | 0.73 | ALDH1A1 (0.36) | CYP1A2ALDH1A1CYP2C19 | |
| SCHEMBL9852982 | 0.69 | PDPK1 (0.43) | CYP1A2ALDH1A1CYP2C19MEN1KMT2A | |
| SCHEMBL7607691 | 0.67 | CCNA2 (0.47) | CYP1A2 | |
| SCHEMBL5392651 | 0.66 | ALDH1A1 (0.32) | CYP1A2ALDH1A1CYP2C19 | |
| SCHEMBL10929799 | 0.64 | ALDH1A1 (0.30) | CYP1A2ALDH1A1CYP2C19 | |
| SCHEMBL8642368 | 0.64 | CCNA2 (0.31) | CYP1A2ALDH1A1CYP2C19 | |
| SCHEMBL17302069 | 0.61 | CYP1A2 (0.52) | CYP1A2CYP2C19MEN1KMT2A | |
| SCHEMBL11390829 | 0.60 | — | — | |
| SCHEMBL11687826 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106232589-B | Tetracarboxylic dianhydride, polyamic acid, polyimides and those manufacturing method and polyamic acid solution | 捷客斯能源株式会社 | 2019-10-22 | — | — | CN | disclosed |
| CN-110167923-A | Tetracarboxylic dianhydride, carbonyls, polyimides forerunner resin and polyimides | JXTG能源株式会社 | 2019-08-23 | — | — | CN | disclosed |
| CN-108473448-A | Ointment | 大塚制药株式会社 | 2018-08-31 | — | — | CN | disclosed |
| CN-107922367-A | Tetracarboxylic dianhydride, carbonyl compound, polyamic acid, polyimide, method for producing same, solution using polyamic acid, and film using polyimide | JXTG能源株式会社 | 2018-04-17 | — | — | CN | disclosed |
| US-8002915-B2 | Gas generant compositions | TK HOLDINGS, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| US-20090008002-A1 | Gas generant compositions | JOYSON SAFETY SYSTEMS ACQUISITION LLC | 2009-01-08 | — | — | US | disclosed |
| WO-2008060366-A2 | GAS GENERANT COMPOSITIONS | TK HOLDINGS, INC. (US) | 2008-05-22 | — | — | WO | disclosed |
| EP-1725548-A2 | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF ASPARTIC ACETAL CASPASE INHIBITORS | Vertex Pharmaceuticals Incorporated (US) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005090334-A2 | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF ASPARTIC ACETAL CASPASE INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2005-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090008002-A1 | Gas generant compositions | CBR3, CBR1, NOX5 | CYP1A2 40/4885ALDH1A1 1527/4885CYP2C19 331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.